Clinical Trial

A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 11, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Exploring the Clinical Application Value of Contrast Enhancement Features in CE-EBUS Images for the Diagnosis of Pulmonary Lesions and Intrapulmonary Lymph Nodes
Trial Details
NCT Number NCT07060378
Lead Sponsor Shanghai Chest Hospital
Conditions Lung Lesions, Mediastinal and Hilar Lymph Node Enlargement
Enrollment 250 participants
Start Date 2025-07-10
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-11